Evogen
8301 State Line Road
Suite 101
Kansas City
Missouri
64114
United States
Tel: 816-360-3895
Fax: 816-931-2451
Website: http://www.evogen.com/
Email: contact@evogen.com
18 articles about Evogen
-
Cognizance Biomarkers Initiates Clinical Trial to Confirm Its Test Can Distinguish Epileptic Seizures from Psychogenic Nonepileptic Seizures
12/4/2019
Cognizance Biomarkers, LLC, a wholly-owned subsidiary of Evogen, Inc., a leader in proteomic and genomic-based testing for improved diagnosis and treatment of neurological disorders, today announced initiation of a clinical trial with Mayo Clinic that aims to confirm its blood-based protein biomarker test and algorithm accurately distinguish epileptic seizures (ES) from psychogenic nonepileptic seizures (PNES)
-
Evogen's Cognizance Biomarkers Presents Data Showing Its Proteomic Biomarkers Have the Potential to Monitor Seizure Burden to Aid in Epilepsy Patient Management
5/28/2019
Cognizance Biomarkers, LLC, a wholly-owned subsidiary of Evogen, Inc., reported it presented data at the 2019 Antiepileptic Drug and Device Trials XV Conference that supports the further development of a biomarker monitoring test to assess seizure burden in epilepsy patients.
-
Evogen Awarded National Institutes of Health SBIR Grant to Advance Its Novel Biomarker-Based Epilepsy Diagnostic
4/10/2019
Collaboration with Human Epilepsy Project will Enhance Evogen's Blood-Based Biomarker Test with the Potential to Transform Epilepsy Diagnosis
-
Evogen's Cognizance Strengthens Intellectual Property Portfolio with Issuance of New U.S. Patent for Its Diagnostic Biomarkers for Epilepsy
10/10/2018
New Patent Provides Further Protection for Neuro-Inflammatory Biomarkers for the Diagnosis of Epileptic Seizures
-
Evogen Receives U.S. Patent Covering Its Novel Epilepsy Blood Test
9/27/2017
-
Evogen Studies Presented At 2016 American Epilepsy Society Annual Meeting Highlight Importance Of Improved Diagnostic Tools For Epilepsy
12/5/2016
-
Evogen And UCB Announce Collaboration For Further Development Of EvoScore START For Improved Diagnosis Of Epilepsy
12/5/2016
-
Evogen To Present At Jefferies and Co. 2014 Global Industrials Conference
8/4/2014
-
Evogen Reports Second Quarter and First Half 2013 Financial Results
8/19/2013
-
Evogen Names New CEO, COO
7/31/2013
-
Evogen Amends and Clarifies Recent Press Release on Sub-Licensing Agreement
4/12/2013
-
Evogen Signs Licensing Agreement With Focus Diagnostics, Inc.
3/13/2013
-
Evogen Adds New Talent to Management Team
2/11/2013
-
Compugen Ltd. Reports Sale of a Portion of Its Evogen Holdings
6/30/2009
-
Evogen Announces the Development of Multi-Faceted H1N1 Influenza Diagnostic Systems
5/6/2009
-
Evogen Expands Executive Team to Launch Affordable, Ultra-Rapid PCR Instrument for High Sensitivity Molecular Diagnostics
2/24/2009
-
Evogen and LGC License High Sensitivity Novel HyBeacons(R) PCR Probe Technology
1/13/2009
-
Evogen Raises $3 Million
11/17/2008